INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 143
RESEARCH DOSSIER / NOT AN ENDORSEMENT

MultiMedRx

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

Talk to a real person, not a machine; doctor-led plans; Brand-name and compounded GLP-1 options; Most insurance accepted; accessible regardless of insurance; 20% avg body weight reduction; 10 lbs in 21 days; 80% report better energy (self-claims); Free expedited delivery; money-back guarantee; in-house compounding; 'nation's leading weight loss management service'

Audienceread

Our read: Adults seeking medical weight loss in CA/CT/FL/OH, price-sensitive, wants human doctor and insurance option (inferred from messaging)

Pricing & termspartial

Semaglutide program: $139 first month; regularly $199 | Tirzepatide program: Not publicly priced in current home card | GLP program prospect offer: $199/month for 3 months; $597 prepaid | Patient Care Fee (terms): $99-$299/month | Clinic-administered semaglutide (terms): From $99 for doses up to 1.25mg

Clinical relationshipspartial

Independent licensed providers on the platform (e.g., Adam Mizeracki MD, Michael Tang MD, PA/NPs); no single group entity named in fetched pages

Pharmacy & fulfillmentpartial

Current homepage repeatedly claims MultiMedRx is a licensed pharmacy compounding in-house; company/about and LinkedIn describe a Telehealth MSO. Legal dispensing entity, license and ownership not independently verified. Local pharmacy route also mentioned in FAQ.

Advertising snapshotsnapshot

Google Ads Transparency Center: Domain filter returned no visible advertiser cards/ads in the signed-out US, last-30-days view. Not proof of zero activity elsewhere. | Meta Ad Library: MultiMedRx page showed ~6 active results; visible card started 10 Oct 2026 (ID 1036607496067600). Copy age-gated. | LinkedIn Ad Library: No results found for MultiMedRx keyword.

Founding yearpartial

2014 per LinkedIn company listing; not independently verified incorporation.

Foundersnot_found

Not established in the pages reviewed.

Location & entity contextpartial

MultiMedRx LLC; 1000 Quail St #260, Newport Beach CA 92663; 401 Ryland St #200-A, Reno NV 89502 (Reno suite looks like a mailbox/registered-agent style address - FLAG, unverified); states served CA/CT/FL/OH

Search visibility samplesnapshot

Title: MMRXShop; Meta description: Not established in the pages reviewed.; Crawler snapshot: 404 - no robots.txt

THE MODERN DOSING WEEKLY

The peptide news
that changes your week.

Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.